Numb contributes to renal fibrosis by promoting tubular epithelial cell cycle arrest at G2/M

Fengxin Zhu(Southern Medical University), Jing Nie(Unknown), Jianwei Tian(Southern Medical University), Tang Li(Beijing Proteome Research Center), Youhua Liu(Guangdong Academy of Sciences), Wei Liu(Second People’s Hospital of Yibin), Jiao Wan(Southern Medical University), Zhanmei Zhou(Southern Medical University), Hao Li(Tianjin Medical University General Hospital), Fan Fan Hou(Southern Medical University)
Oncotarget
March 21, 2016
10.18632/oncotarget.8238
Cited by 27

Related Papers

Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|609
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587